I don’t disagree with any of your points. I’d just like to add...

I don’t disagree with any of your points. I’d just like to add that the assay results we are waiting on were from locations not considered high priority. So let’s not throw in the towel IF the assay results come back and the market considers to be “poor”. We should instead look at the assay results in the context of the potential of the Andover project.

I suspect the market is going to take a harsh view of the initial assay results. My opinion only.